SELNECITY

Serial Number 79398416
774

Registration Progress

Application Filed
May 6, 2024
Under Examination
Approved for Publication
Dec 11, 2024
Published for Opposition
Dec 17, 2024
Registered

Attorney Assistance

Opposition Instituted
Due: Jul 28, 2025 9 days

Trademark Image

SELNECITY

Basic Information

Serial Number
79398416
Filing Date
May 6, 2024
Published for Opposition
December 17, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
774
Status Date
Jun 18, 2025
Application
Pending
Classes
005

Rights Holder

Boehringer Ingelheim International GmbH

03
Address
55218 Ingelheim
DE

Ownership History

Boehringer Ingelheim International GmbH

Original Applicant
03
DE

Boehringer Ingelheim International GmbH

Owner at Publication
03
DE

Legal Representation

Attorney
MAX MOSKOWITZ

USPTO Deadlines

Next Deadline
9 days remaining
Opposition Instituted
Due Date
July 28, 2025

Application History

14 events
Date Code Type Description Documents
Jul 5, 2025 RFNP P REFUSAL PROCESSED BY IB Loading...
Jun 18, 2025 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Jun 18, 2025 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Jun 16, 2025 OPNS B OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Loading...
Jun 15, 2025 OPNC E OPPOSITION NOTICE (IB REFUSAL) CREATED Loading...
Jan 16, 2025 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Dec 17, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 11, 2024 NPUB O NOTICE OF PUBLICATION Loading...
Nov 21, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 19, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 24, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 23, 2024 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jun 27, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.

Classification

International Classes
005